Myomo profit margin MYO
Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.
- Net margin, 12 months
- −33.5%
- Operating margin, 12 months
- −27.1%
- Net margin on a year earlier
- −10.7 pts
- Peer median
- 8.4%
Over the twelve months to Jun 30, 2026, Myomo kept −33.5% of its revenue as net profit, with an operating margin of −27.1% and a gross margin of 68.4%.
Five years earlier its net margin was −90.1%.
The median for 7 medical instruments and supplies stocks of a similar size is 8.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −38.1% | −35.2% | 65.7% |
| FY2024 | −19.0% | −19.1% | 71.2% |
| FY2023 | −42.3% | −42.8% | 68.5% |
| FY2022 | −68.9% | −68.7% | 65.8% |
| FY2021 | −74.9% | −74.1% | 74.4% |
| FY2020 | n/a | n/a | 65.7% |
| FY2019 | n/a | n/a | 63.0% |
| FY2018 | n/a | n/a | 70.2% |
| FY2017 | n/a | n/a | 67.6% |
| FY2016 | n/a | n/a | 74.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −33.5% | −10.7 pts | −27.1% | |
| Q1 FY26 | −36.7% | −21.6 pts | −34.1% | |
| Q4 FY25 | −38.1% | −19.1 pts | −35.2% | |
| Q3 FY25 | −28.9% | +4.4 pts | −28.5% | |
| Q2 FY25 | −22.9% | +21.9 pts | −22.8% | |
| Q1 FY25 | −15.0% | +32.7 pts | −15.1% | |
| Q4 FY24 | −19.0% | +23.3 pts | −19.1% | |
| Q3 FY24 | −33.2% | +9.2 pts | −33.3% | |
| Q2 FY24 | −44.7% | +5.0 pts | −44.8% | |
| Q1 FY24 | −47.8% | +21.9 pts | −48.3% | |
| Q4 FY23 | −42.3% | +26.6 pts | −42.8% | |
| Q3 FY23 | −42.4% | +30.2 pts | −43.3% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Myomo's size, closest first, today.
| Company | Profit margin |
|---|---|
| MYOMyomo | −33.5% |
| APTAlpha Pro Tech | 6.8% |
| NEPHNephros | 8.4% |
| KEQUKewaunee Scientific | 3.0% |
| PDEXPro DEX | 17.6% |
| UTMDUtah Medical Products | 29.0% |
| INFUInfuSystem | 6.0% |
| EMBCEmbecta | 8.6% |
| Peer median | 8.4% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Myomo
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.